Net Medical Xpress Solutions, Inc.
NMXS
$0.0099
-$0.0012-10.81%
| Weiss Ratings | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.20 | |||
| Price History | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.81% | |||
| 30-Day Total Return | 19.28% | |||
| 60-Day Total Return | 19.28% | |||
| 90-Day Total Return | -20.16% | |||
| Year to Date Total Return | 19.28% | |||
| 1-Year Total Return | -50.25% | |||
| 2-Year Total Return | -85.88% | |||
| 3-Year Total Return | -85.00% | |||
| 5-Year Total Return | -82.00% | |||
| 52-Week High % Change | -53.65% | |||
| 52-Week Low % Change | 38.75% | |||
| Price | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.02 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Jan 24, 2025 | |||
| 52-Week High Price (Date) | May 28, 2024 | |||
| Valuation | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 418.11K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 505 255 1999 | |||
| Address | 8206 Louisiana Boulevard NE Albuquerque, NM 87113 | |||
| Website | netmedical.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -7.96% | |||
| Profit Margin | -11.33% | |||
| Management Effectiveness | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -15.05% | |||
| Return on Equity | -- | |||
| Income Statement | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.67M | |||
| Total Revenue (TTM) | 2.67M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 689.00K | |||
| EBITDA (TTM) | -204.00K | |||
| EBIT (TTM) | -213.00K | |||
| Net Income (TTM) | -303.00K | |||
| Net Income Avl. to Common (TTM) | -303.00K | |||
| Total Revenue Growth (Q YOY) | -3.53% | |||
| Earnings Growth (Q YOY) | 56.35% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | 72.00% | |||
| Balance Sheet | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 226.00K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 565.00K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 195.00K | |||
| Current Ratio (Q) | 1.054 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 536.00K | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | 195.00K | |||
| Cash Flow | NMXS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -13.00K | |||
| Net Change in Cash (TTM) | -202.00K | |||
| Levered Free Cash Flow (TTM) | -109.30K | |||
| Cash from Operations (TTM) | -189.00K | |||
